Methamphetamine increases HIV infectivity in neural progenitor cells

Marta Skowronska, Marisa McDonald, Martina Velichkovska, Ana Rachel Leda, Minseon Park, Michal J Toborek

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNFκB/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100μM). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH.METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NFκB and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NFκB/SP1-dependent activation of theHIVLTRandwith the subsequent alterations of NPC neurogenesis. Such events may underlie METH- exacerbated neurocognitive dysfunction in HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)296-311
Number of pages16
JournalJournal of Biological Chemistry
Volume293
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Methamphetamine
Stem Cells
HIV
HIV Infections
Viruses
Neurogenesis
Viral Load
Chemical activation
HIV-1

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Methamphetamine increases HIV infectivity in neural progenitor cells. / Skowronska, Marta; McDonald, Marisa; Velichkovska, Martina; Rachel Leda, Ana; Park, Minseon; Toborek, Michal J.

In: Journal of Biological Chemistry, Vol. 293, No. 1, 01.01.2018, p. 296-311.

Research output: Contribution to journalArticle

Skowronska, Marta ; McDonald, Marisa ; Velichkovska, Martina ; Rachel Leda, Ana ; Park, Minseon ; Toborek, Michal J. / Methamphetamine increases HIV infectivity in neural progenitor cells. In: Journal of Biological Chemistry. 2018 ; Vol. 293, No. 1. pp. 296-311.
@article{c72ca7defe1f4e169de3379ae5813060,
title = "Methamphetamine increases HIV infectivity in neural progenitor cells",
abstract = "HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNFκB/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100μM). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH.METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NFκB and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NFκB/SP1-dependent activation of theHIVLTRandwith the subsequent alterations of NPC neurogenesis. Such events may underlie METH- exacerbated neurocognitive dysfunction in HIV-infected patients.",
author = "Marta Skowronska and Marisa McDonald and Martina Velichkovska and {Rachel Leda}, Ana and Minseon Park and Toborek, {Michal J}",
year = "2018",
month = "1",
day = "1",
doi = "10.1074/jbc.RA117.000795",
language = "English (US)",
volume = "293",
pages = "296--311",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "1",

}

TY - JOUR

T1 - Methamphetamine increases HIV infectivity in neural progenitor cells

AU - Skowronska, Marta

AU - McDonald, Marisa

AU - Velichkovska, Martina

AU - Rachel Leda, Ana

AU - Park, Minseon

AU - Toborek, Michal J

PY - 2018/1/1

Y1 - 2018/1/1

N2 - HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNFκB/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100μM). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH.METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NFκB and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NFκB/SP1-dependent activation of theHIVLTRandwith the subsequent alterations of NPC neurogenesis. Such events may underlie METH- exacerbated neurocognitive dysfunction in HIV-infected patients.

AB - HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNFκB/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100μM). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH.METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NFκB and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NFκB/SP1-dependent activation of theHIVLTRandwith the subsequent alterations of NPC neurogenesis. Such events may underlie METH- exacerbated neurocognitive dysfunction in HIV-infected patients.

UR - http://www.scopus.com/inward/record.url?scp=85040096070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040096070&partnerID=8YFLogxK

U2 - 10.1074/jbc.RA117.000795

DO - 10.1074/jbc.RA117.000795

M3 - Article

C2 - 29158267

AN - SCOPUS:85040096070

VL - 293

SP - 296

EP - 311

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 1

ER -